BPC-157

What BPC-157 is, structurally

BPC-157 is a pentadecapeptide, fifteen residues joined by ordinary amide bonds, with a free N-terminal amine and a free C-terminal acid.

The most distinctive feature is the proline content. Four of the fifteen residues are proline, and three of them run consecutively at positions three to five. Proline's side chain loops back onto its own backbone nitrogen, which removes the amide hydrogen and restricts rotation. A run of three in a row produces a genuinely rigid segment that resists folding into ordered secondary structure, so this is a conformationally constrained peptide rather than a flexible chain.

Charge follows from four residues. One glutamate and two aspartates carry negative charges at neutral pH, against a single lysine carrying a positive one. The peptide is therefore net negative in ordinary working conditions, and combined with the absence of any large hydrophobic block it is polar and water soluble. No quantitative figure is quoted here.

Two absences matter as much as what is present. There is no cysteine, so there is no free thiol, no disulfide bonding and no need for a reducing agent. There is also no tryptophan, tyrosine or phenylalanine, meaning the sequence contains no aromatic ring anywhere. That has a direct consequence for how purity is measured, covered below.

Reconstitution and handling

Sterile water is the default solvent. There is no metal center to protect, so PBS or an appropriate assay buffer are equally reasonable. Add diluent slowly down the inside wall of the vial, swirl gently rather than vortexing, and let the solution stand until it clarifies. Shear and foaming drive aggregation at the air-liquid interface, which is the reason to avoid vortexing.

At low concentration, adsorption onto plasticware is worth allowing for. Peptides bind to polypropylene surfaces and a measured concentration can fall below the prepared one for that reason alone. Low-protein-binding tubes reduce the loss. This peptide is net negative rather than net positive, so untreated glass is less of a concern here than it is for a basic peptide.

This is laboratory preparation chemistry, not dosing, administration, or protocol guidance of any kind.

Storage and stability

Store the lyophilized powder at -20 degrees C, sealed, desiccated and protected from light. Let a cold vial reach room temperature before opening so condensation does not reach the powder. Once reconstituted, hold at 2 to 8 degrees C for short-term work, or aliquot and freeze for longer storage so no vial is thawed twice.

The degradation profile is unusually clean, and the sequence shows why. No cysteine means no thiol to oxidize. No methionine means no sulfoxide route. No asparagine and no glutamine means deamidation, the most common peptide liability, does not apply. What remains is the pair of adjacent aspartates at positions ten and eleven. Aspartate residues can cyclize to a succinimide intermediate and open again as isoaspartate, rearranging the backbone without changing the mass, and this is the fastest chemical route available to this particular sequence in aqueous solution. Near-neutral pH and cold storage limit it.

These are storage conditions for the material, not dosing or administration guidance.

How BPC-157 is tested

Reversed-phase HPLC establishes chromatographic purity, reported as area percent. Detection wavelength is not a free choice here. With no tryptophan, tyrosine or phenylalanine in the sequence, there is no aromatic chromophore and no absorbance at 280 nm, so purity has to be measured in the low UV at around 214 nm where the amide bond itself absorbs. A 280 nm method would see almost nothing.

Area percent is a chromatographic measure and not peptide content by weight. Solid-phase synthesis yields a salt, commonly trifluoroacetate or acetate, and that counter-ion sits outside the molecular weight quoted above, so the mass in the vial is not all peptide. Residual trifluoroacetate, truncated chains and deletion sequences are the impurity classes chromatography is expected to resolve. The proline-rich segment is the plausible weak point during synthesis, since consecutive prolines couple poorly and deletion products are most likely to arise there.

Mass spectrometry confirms identity against the expected molecular weight. It has one blind spot worth stating: isoaspartate has the same mass as aspartate, so the isomerization described above is invisible to mass alone and has to be caught chromatographically.

These describe general methodology, not a claim about any particular batch.

Handling FAQ

Why is purity reported at 214 nm rather than 280 nm? Because the sequence contains no aromatic residue. Tryptophan, tyrosine and phenylalanine are what give a peptide absorbance near 280 nm, and none of the fifteen residues here is aromatic. The amide bond absorbs in the low UV instead, so 214 nm is the usable wavelength.

Can mass spectrometry detect the main degradation route? No. The aspartate-to-isoaspartate rearrangement moves the backbone without adding or removing atoms, so the mass is unchanged and the mass spectrum looks identical. Chromatographic separation, not mass, is what resolves it.

Full specifications for BPC-157.